 |
인쇄하기
취소
|
Daewoong rekindling strategic alliance flame
Daewoong Pharm is actively seeking strategic alliances with a number of multinational pharmaceutical firms using its strong sales and marketing force.
Daewoong and MSD Korea have recently agreed to jointly market Januvia (sitagliptin phosphate) under their second strategic alliance following Fosamax Plus last March. Januvia is an oral diabetes medication in a new class of drugs known as DPP-...
Daewoong and MSD Korea have recently agreed to jointly market Januvia (sitagliptin phosphate) under their second strategic alliance following Fosamax Plus last March. Januvia is an oral diabetes medication in a new class of drugs known as DPP-...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.